Literature DB >> 10155305

Clinical and economic aspects of prophylaxis and treatment of Pneumocystis carinii pneumonia.

K A Freedberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 10155305     DOI： 10.2165/00019053-199507020-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  19 in total

1.  A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

Authors:  S A Bozzette; F R Sattler; J Chiu; A W Wu; D Gluckstein; C Kemper; A Bartok; J Niosi; I Abramson; J Coffman
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

2.  Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone.

Authors:  W T Hughes; W Kennedy; M Dugdale; M A Land; D S Stein; J J Weems; S Palte; D Lancaster; S Gidan-Kovnar; R E Morrison
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

3.  Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.

Authors:  J E Conte; D Chernoff; D W Feigal; P Joseph; C McDonald; J A Golden
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

4.  A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

Authors:  B Hirschel; A Lazzarin; P Chopard; M Opravil; H J Furrer; S Rüttimann; P Vernazza; J P Chave; F Ancarani; V Gabriel
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

5.  Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

Authors:  S D Nightingale; D W Cameron; F M Gordin; P M Sullam; D L Cohn; R E Chaisson; L J Eron; P D Sparti; B Bihari; D L Kaufman
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

6.  Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.

Authors:  W Hughes; G Leoung; F Kramer; S A Bozzette; S Safrin; P Frame; N Clumeck; H Masur; D Lancaster; C Chan
Journal:  N Engl J Med       Date:  1993-05-27       Impact factor: 91.245

7.  A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.

Authors:  M M Schneider; A I Hoepelman; J K Eeftinck Schattenkerk; T L Nielsen; Y van der Graaf; J P Frissen; I M van der Ende; A F Kolsters; J C Borleffs
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

8.  Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.

Authors:  G S Leoung; D W Feigal; A B Montgomery; K Corkery; L Wardlaw; M Adams; D Busch; S Gordon; M A Jacobson; P A Volberding
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

9.  Dapsone as a single agent is suboptimal therapy for Pneumocystis carinii pneumonia.

Authors:  S Safrin; F R Sattler; B L Lee; T Young; R Bill; C T Boylan; J Mills
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

10.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.